Loading
Life sciences · Journal article
International Journal of Pharmaceutical and Bio-medical Science · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Breast cancer is the most common malignancy among women worldwide. Conventional treatment involves surgery, chemotherapy, radiotherapy, and hormone therapy. Integrative approaches such as Yoga Prana Vidya (YPV) healing have shown promise in improving patient outcomes by reducing stress, pain, and enhancing recovery. Case Presentation: A 48‑year‑old female, diagnosed with Stage II multifocal invasive ductal carcinoma of the left breast underwent modified radical mastectomy with sentinel lymph node biopsy. Histopathology confirmed malignancy, but lymph nodes were negative. Prognostic assessment using CanAssist Breast placed her in the low‑risk category for recurrence. YPV Intervention: The patient received 112 healing sessions over 55 days (twice daily, 15–20 minutes each), alongside daily practice of breathing, forgiveness, meditation, and exercises, from the YPV Sadhana App. Healing protocols included psychological healing, affected organ healing, internal organ cleansing, and blood purification. Results: Within two sessions, sleep improved from two to four hours. After 20 sessions, pain reduced by 30–40%. By 70 sessions, stiffness and pain reduced by 80–90%, enabling household work. At completion, medical tests confirmed chemotherapy was not required. The patient was placed in the low‑risk recurrence category and advised hormone therapy only. Conclusion: YPV healing contributed to significant improvements in sleep, pain reduction, stress management, and functional recovery. This case highlights the potential of YPV as an integrative adjunct to conventional breast cancer management.